Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Galantamine”

89 trials

Showing 20 of 89 results

Not applicableStudy completedNCT00299676
What this trial is testing

An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period

Who this might be right for
Alzheimer DiseaseDementiaGalantamine
Janssen-Cilag Pty Ltd 61
Testing effectiveness (Phase 2)Study completedNCT01012167
What this trial is testing

Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 86
Large-scale testing (Phase 3)Ended earlyNCT00679627
What this trial is testing

Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen Research & Development, LLC 2,051
Large-scale testing (Phase 3)Study completedNCT00463879
What this trial is testing

Galantamine for Cognitive Deficits in Schizophrenia

Who this might be right for
Schizophrenia
Yale University 21
Large-scale testing (Phase 3)Study completedNCT00814801
What this trial is testing

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen Pharmaceutical K.K. 580
Not applicableStudy completedNCT00161044
What this trial is testing

An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms

Who this might be right for
Chronic Schizophrenia
University of Maryland, Baltimore 20
Large-scale testing (Phase 3)Study completedNCT00082602
What this trial is testing

Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 83
Post-approval studies (Phase 4)Study completedNCT00216515
What this trial is testing

The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Janssen Korea, Ltd., Korea 102
Early research (Phase 1)Study completedNCT00645554
What this trial is testing

A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers

Who this might be right for
Pharmacokinetics
Xian-Janssen Pharmaceutical Ltd. 2
Post-approval studies (Phase 4)Ended earlyNCT00369603
What this trial is testing

Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Duke University 4
Post-approval studies (Phase 4)Study completedNCT00814658
What this trial is testing

The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life

Who this might be right for
Dementia
Janssen-Cilag Farmaceutica Ltda. 22
Not applicableStudy completedNCT01009476
What this trial is testing

Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine

Who this might be right for
DementiaAlzheimer DiseaseDementia, Vascular
Janssen-Cilag G.m.b.H 1,134
Post-approval studies (Phase 4)Study completedNCT01054976
What this trial is testing

The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen Korea, Ltd., Korea 99
Large-scale testing (Phase 3)Study completedNCT00253227
What this trial is testing

The Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 387
Post-approval studies (Phase 4)UnknownNCT00219869
What this trial is testing

Galantamine in the Treatment of Post-Traumatic Headache

Who this might be right for
Post-Traumatic HeadacheHead Trauma,ClosedRetention Disorders,Cognitive
Rapoport, Alan, M.D. 30
Post-approval studies (Phase 4)Ended earlyNCT00423969
What this trial is testing

Galantamine Augmentation of Escitalopram for Treatment of Depression

Who this might be right for
Depression
Indiana University 20
Post-approval studies (Phase 4)Study completedNCT00195845
What this trial is testing

A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder

Who this might be right for
Bipolar Disorder
Cambridge Health Alliance 30
Not applicableStudy completedNCT01029132
What this trial is testing

Characteristics of Treatment Responders to Galantamine

Who this might be right for
Dementia
Samsung Medical Center 66
Testing effectiveness (Phase 2)Study completedNCT02872857
What this trial is testing

Subarachnoid Hemorrhage Recovery And Galantamine

Who this might be right for
Subarachnoid Hemorrhage
The University of Texas Health Science Center, Houston 60
Large-scale testing (Phase 3)Looking for participantsNCT07003386
What this trial is testing

Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke AIS
Shanghai Yueyang Integrated Medicine Hospital 66
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation